ELTP — Elite Pharma Inc · rev $148.9M

Elite Pharma Inc (ELTP) is a drug manufacturers - specialty & generic company listed on US.

Latest reported ELTP revenue for 2026-03-31 was $148.9M. Net income was $44.9M. Revenue was up 77.1% from 2025-03-31 to 2026-03-31. ELTP currently screens at market cap $659.0M.

Use this ELTP page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ELTP quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ELTP SEC filings page. Lician reads the product cache first so this HTML stays unique to Elite Pharma Inc even when a live quote feed is slow.

Elite Pharma Inc latest statements (FY2026)

Latest cached year on this hub. Full ELTP income, balance, and cash tables.

  • Revenue$148.9M
  • Net Income$44.9M
  • Total Assets$138.3M
  • Total Debt$0
  • Free Cash Flow$22.8M

ELTP recent filings